Zis A P, Haskett R F, Albala A A, Carroll B J
Prog Neuropsychopharmacol Biol Psychiatry. 1983;7(4-6):563-8. doi: 10.1016/0278-5846(83)90026-x.
Several lines of evidence indicate that the activity of the hypothalamus-pituitary-adrenal (HPA) axis in depression is disinhibited. Escape from dexamethasone suppression, although not limited to is more frequent in patients with endogenous depression compared to normals or patients with other psychiatric diagnoses. Norepinephrine, serotonin and acetylcholine have been implicated in the pathophysiology of this neuroendocrine abnormality. Morphine, 5 mg intravenously, suppressed cortisol secretion in healthy volunteers (n = 4) and the majority of 32 psychiatric inpatients. However, patients with endogenous depression and abnormal dexamethasone suppression test results show early resumption (escape) of cortisol secretion following the initial suppression induced by morphine. It is concluded that the pathophysiology of this neuroendocrine abnormality is not limited to classical neurotransmitter-HPA axis interaction but that it also involves opioid inhibitory mechanisms.
多条证据表明,抑郁症患者下丘脑 - 垂体 - 肾上腺(HPA)轴的活动受到抑制。地塞米松抑制试验脱逸现象(虽然不限于该现象)在内源性抑郁症患者中比正常人或患有其他精神疾病诊断的患者更常见。去甲肾上腺素、血清素和乙酰胆碱与这种神经内分泌异常的病理生理学有关。静脉注射5毫克吗啡可抑制健康志愿者(n = 4)和32名精神科住院患者中的大多数人的皮质醇分泌。然而,内源性抑郁症患者且地塞米松抑制试验结果异常者,在吗啡诱导的初始抑制后,皮质醇分泌会早期恢复(脱逸)。得出的结论是,这种神经内分泌异常的病理生理学不仅限于经典神经递质 - HPA轴相互作用,还涉及阿片类抑制机制。